![Filip Borgions](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Filip Borgions
Director Técnico/Científico/I+D en
ARGENX SE
.
Perfil
Filip Borgions currently works at argenx SE, as Chief Technology Innovation Officer.
Dr. Borgions also formerly worked at Thrombogenics, Inc., as Principal.
Dr. Borgions received his undergraduate degree and doctorate degree from Katholieke Universiteit Leuven.
Cargos activos de Filip Borgions
| Empresas | Cargo | Inicio |
|---|---|---|
| ARGENX SE | Director Técnico/Científico/I+D | 01/01/2015 |
Antiguos cargos conocidos de Filip Borgions.
| Empresas | Cargo | Fin |
|---|---|---|
Thrombogenics, Inc.
 Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company engages in delivering innovative treatments for diseases of the back of the eye with a focus on diabetic eye disease | Corporate Officer/Principal | - |
Formación de Filip Borgions.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
14
Relaciones de 1er grado
3
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Katholieke Universiteit Leuven
 Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
argenx SE
 argenx SE BiotechnologyHealth Technology Develops therapies and medicines for the treatment of autoimmune diseases | Health Technology |
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company engages in delivering innovative treatments for diseases of the back of the eye with a focus on diabetic eye disease | Commercial Services |
- Bolsa de valores
- Insiders
- Filip Borgions
Elige MarketScreener 
